DDReg Pharma

Insights

Nanobodies vs antibodies in the fight against Covid

Nanobodies vs antibodies in the fight against Covid

Nanobodies are engineered small proteins that recognize and specifically bind

Enhancing drug discovery processes through artificial intelligence

Enhancing drug discovery processes through artificial intelligence

From pre-clinical phases to post-marketing follow up studies, the drug

The impact of the Russia-Ukraine war on clinical trials

The impact of the Russia-Ukraine war on clinical trials

The Russia-Ukraine war has undoubtedly affected millions of people in

DDReg’s RegTech space: your regulatory solution for achieving rapid market access

DDReg’s RegTech space: your regulatory solution for achieving rapid market access

RegTech focuses on technologies that may facilitate the delivery of

Biologics development & regulatory approval – EMA perspective

Biologics development & regulatory approval – EMA perspective

Biologic medicinal products, particularly biosimilars, have revolutionized the treatment of

Biosimilarity and Interchangeability in the MENA region

Biosimilarity and Interchangeability in the MENA region

A biological drug (or biologic) is one that is produced

Biosimilars in the Emerging World

Biosimilars in the Emerging World

Over the last five years, biosimilars have progressively gained traction.

African Medicines Agency

African Medicines Agency

In 2019, the African Union’s Bureau of Heads of State

Integrative Medicine

Integrative Medicine

Integral health integrates traditional treatment in a coordinated way with

Send us a Message
No, thank you.